Foundry DelEqu Industry-Neutral Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1RTX | RTX CORP | Industrials | $260.60B | 9.20% |
2SCCO | SOUTHERN COPPER CORP | Basic Materials | $142.48B | 5.03% |
3CRM | SALESFORCE INC | Technology | $139.86B | 4.94% |
4SYK | STRYKER CORP | Healthcare | $122.63B | 4.33% |
5ISRG | INTUITIVE SURGICAL INC | Healthcare | $122.33B | 4.32% |
6LMT | LOCKHEED MARTIN CORP | Industrials | $117.30B | 4.14% |
7MDT | MEDTRONIC PLC | Healthcare | $106.50B | 3.76% |
8NEM | NEWMONT CORP | Basic Materials | $95.76B | 3.38% |
9FCX | FREEPORT-MCMORAN INC | Basic Materials | $83.92B | 2.96% |
10MMM | 3M CO | Industrials | $83.37B | 2.94% |
11HON | HONEYWELL INTERNATIONAL INC | Industrials | $71.29B | 2.52% |
12TDG | TRANSDIGM GROUP INC | Industrials | $67.93B | 2.40% |
13BSX | BOSTON SCIENTIFIC CORP | Healthcare | $65.44B | 2.31% |
14EW | EDWARDS LIFESCIENCES CORP | Healthcare | $49.36B | 1.74% |
15MSCI | MSCI INC | Financial Services | $45.77B | 1.62% |
16MCHP | MICROCHIP TECHNOLOGY INC | Technology | $43.89B | 1.55% |
17BDX | BECTON DICKINSON & CO | Healthcare | $43.58B | 1.54% |
18KDP | KEURIG DR PEPPER INC | Consumer Defensive | $42.05B | 1.49% |
19AXON | AXON ENTERPRISE INC | Industrials | $41.13B | 1.45% |
20RVMD | REVOLUTION MEDICINES INC | Healthcare | $39.58B | 1.40% |
21VMC | VULCAN MATERIALS CO | Basic Materials | $37.41B | 1.32% |
22WDAY | WORKDAY INC | Technology | $35.76B | 1.26% |
23ON | ON SEMICONDUCTOR CORP | Technology | $34.24B | 1.21% |
24DXCM | DEXCOM INC | Healthcare | $29.58B | 1.04% |
25FICO | FAIR ISAAC CORP | Technology | $29.15B | 1.03% |
26RMD | RESMED INC | Healthcare | $28.86B | 1.02% |
27GEHC | GE HEALTHCARE TECHNOLOGIES INC | Healthcare | $28.69B | 1.01% |
28ECHO | ECHO GLOBAL LOGISTICS INC | Industrials | $26.66B | 0.94% |
29VRSK | VERISK ANALYTICS INC | Industrials | $26.29B | 0.93% |
30VRSN | VERISIGN INC | Technology | $25.27B | 0.89% |
31MRNA | MODERNA INC | Healthcare | $24.53B | 0.87% |
32UTHR | UNITED THERAPEUTICS CORP | Healthcare | $22.74B | 0.80% |
33STE | STERIS PLC | Healthcare | $21.26B | 0.75% |
34FTV | FORTIVE CORP | Technology | $18.83B | 0.67% |
35DD | DUPONT DE NEMOURS INC | Basic Materials | $18.49B | 0.65% |
36ZBH | ZIMMER BIOMET HOLDINGS INC | Healthcare | $17.63B | 0.62% |
37BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 0.56% |
38SOLV | SOLVENTUM CORP | Healthcare | $14.08B | 0.50% |
39COO | COOPER COMPANIES INC | Healthcare | $13.99B | 0.49% |
40CSL | CARLISLE COMPANIES INC | Basic Materials | $13.98B | 0.49% |
41PINS | PINTEREST INC | Communication Services | $13.00B | 0.46% |
42MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $12.76B | 0.45% |
43ALGN | ALIGN TECHNOLOGY INC | Healthcare | $12.66B | 0.45% |
44PEN | PENUMBRA INC | Healthcare | $12.52B | 0.44% |
45COKE | COCA-COLA CONSOLIDATED INC | Consumer Defensive | $12.03B | 0.42% |
46BF.B | BROWN FORMAN CORP | Consumer Defensive | $11.74B | 0.41% |
47BAX | BAXTER INTERNATIONAL INC | Healthcare | $11.68B | 0.41% |
48PODD | INSULET CORP | Healthcare | $11.36B | 0.40% |
49CART | INSTACART (MAPLEBEAR INC) | Consumer Cyclical | $10.77B | 0.38% |
50GMED | GLOBUS MEDICAL INC | Healthcare | $10.45B | 0.37% |
51CYTK | CYTOKINETICS INC | Healthcare | $9.98B | 0.35% |
52IT | GARTNER INC | Technology | $9.39B | 0.33% |
53HALO | HALOZYME THERAPEUTICS INC | Healthcare | $9.23B | 0.33% |
54GKOS | GLAUKOS CORP | Healthcare | $9.21B | 0.33% |
55IBRX | IMMUNITYBIO INC | Healthcare | $8.04B | 0.28% |
56RAL | RALLIANT CORP | Technology | $7.85B | 0.28% |
57MBLY | MOBILEYE GLOBAL INC | Consumer Cyclical | $7.76B | 0.27% |
58TAP | MOLSON COORS BEVERAGE CO | Consumer Defensive | $7.28B | 0.26% |
59DBX | DROPBOX INC | Technology | $7.14B | 0.25% |
60LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.25% |
61PAYC | PAYCOM SOFTWARE INC | Technology | $7.05B | 0.25% |
62RIOT | RIOT PLATFORMS INC | Financial Services | $6.91B | 0.24% |
63CHE | CHEMED CORP | Healthcare | $6.77B | 0.24% |
64CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.24% |
65MSA | MSA SAFETY INC | Industrials | $6.60B | 0.23% |
66MXL | MAXLINEAR INC | Technology | $6.43B | 0.23% |
67CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.22% |
68MIDD | MIDDLEBY CORP | Industrials | $6.02B | 0.21% |
69TFX | TELEFLEX INC | Healthcare | $5.96B | 0.21% |
70BLCO | BAUSCH & LOMB CORP | Healthcare | $5.80B | 0.20% |
71CLF | CLEVELAND-CLIFFS INC | Basic Materials | $5.29B | 0.19% |
72KNF | KNIFE RIVER CORP | Basic Materials | $4.64B | 0.16% |
73LIVN | LIVANOVA PLC | Healthcare | $4.43B | 0.16% |
74LBRDA | LIBERTY BROADBAND CORP | Communication Services | $4.43B | 0.16% |
75MDU | MDU RESOURCES GROUP INC | Industrials | $4.42B | 0.16% |
76MMSI | MERIT MEDICAL SYSTEMS INC | Healthcare | $4.41B | 0.16% |
77NVST | ENVISTA HOLDINGS CORP | Healthcare | $4.35B | 0.15% |
78CELC | CELCUITY INC | Healthcare | $4.31B | 0.15% |
79VKTX | VIKING THERAPEUTICS INC | Healthcare | $4.31B | 0.15% |
80EXLS | EXLSERVICE HOLDINGS INC | Technology | $4.30B | 0.15% |
81UCTT | ULTRA CLEAN HOLDINGS INC | Technology | $4.14B | 0.15% |
82MARA | MARA HOLDINGS INC | Financial Services | $4.08B | 0.14% |
83BFAM | BRIGHT HORIZONS FAMILY SOLUTIONS INC | Consumer Cyclical | $4.03B | 0.14% |
84ICUI | ICU MEDICAL INC | Healthcare | $3.94B | 0.14% |
85POWI | POWER INTEGRATIONS INC | Technology | $3.93B | 0.14% |
86RLAY | RELAY THERAPEUTICS INC | Healthcare | $3.81B | 0.13% |
87LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.72B | 0.13% |
88DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.70B | 0.13% |
89IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.64B | 0.13% |
90AB | ALLIANCEBERNSTEIN HOLDING LP | Financial Services | $3.54B | 0.13% |
91HAE | HAEMONETICS CORP | Healthcare | $3.54B | 0.12% |
92CLSK | CLEANSPARK INC | Financial Services | $3.34B | 0.12% |
93SEDG | SOLAREDGE TECHNOLOGIES INC | Technology | $3.25B | 0.11% |
94WRBY | WARBY PARKER INC | Healthcare | $3.24B | 0.11% |
95ACHC | ACADIA HEALTHCARE COMPANY INC | Healthcare | $3.17B | 0.11% |
96CARG | CARGURUS INC | Consumer Cyclical | $3.16B | 0.11% |
97PENG | PENGUIN SOLUTIONS INC | Technology | $3.10B | 0.11% |
98EXPO | EXPONENT INC | Industrials | $3.05B | 0.11% |
99AD | ARRAY DIGITAL INFRASTRUCTURE INC | Communication Services | $3.02B | 0.11% |
100LUNR | INTUITIVE MACHINES INC | Industrials | $2.93B | 0.10% |
101RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $2.88B | 0.10% |
102LCID | LUCID GROUP INC | Consumer Cyclical | $2.87B | 0.10% |
103XRAY | DENTSPLY SIRONA INC | Healthcare | $2.81B | 0.10% |
104CLDX | CELLDEX THERAPEUTICS INC | Healthcare | $2.77B | 0.10% |
105ESTA | ESTABLISHMENT LABS HOLDINGS INC | Healthcare | $2.72B | 0.10% |
106GRND | GRINDR INC | Technology | $2.71B | 0.10% |
107TMDX | TRANSMEDICS GROUP INC | Healthcare | $2.56B | 0.09% |
108DCO | DUCOMMUN INC | Industrials | $2.54B | 0.09% |
109RUM | RUMBLE INC | Technology | $2.51B | 0.09% |
110TALO | TALOS ENERGY INC | Energy | $2.49B | 0.09% |
111ATRO | ASTRONICS CORP | Industrials | $2.41B | 0.09% |
112BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.08% |
113AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $2.36B | 0.08% |
114BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.08% |
115LMAT | LEMAITRE VASCULAR INC | Healthcare | $2.32B | 0.08% |
116INTA | INTAPP INC | Technology | $2.24B | 0.08% |
117SION | SIONNA THERAPEUTICS INC | Healthcare | $2.23B | 0.08% |
118NWL | NEWELL BRANDS INC | Consumer Defensive | $2.22B | 0.08% |
119AGL | AGILON HEALTH INC | Healthcare | $2.17B | 0.08% |
120CDNA | CAREDX INC | Healthcare | $2.05B | 0.07% |
121NUVB | NUVATION BIO INC | Healthcare | $2.03B | 0.07% |
122SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | $2.02B | 0.07% |
123PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.07% |
124URGN | UROGEN PHARMA LTD | Healthcare | $1.96B | 0.07% |
125UFPT | UFP TECHNOLOGIES INC | Healthcare | $1.87B | 0.07% |
126MRVI | MARAVAI LIFESCIENCES HOLDINGS INC | Healthcare | $1.87B | 0.07% |
127SAM | BOSTON BEER CO INC | Consumer Defensive | $1.86B | 0.07% |
128MQ | MARQETA INC | Technology | $1.85B | 0.07% |
129NVCR | NOVOCURE LTD | Healthcare | $1.84B | 0.07% |
130FUN | SIX FLAGS ENTERTAINMENT CORPORATION | Consumer Cyclical | $1.79B | 0.06% |
131NN | NEXTNAV INC | Technology | $1.78B | 0.06% |
132ATRC | ATRICURE INC | Healthcare | $1.77B | 0.06% |
133ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.06% |
134AESI | ATLAS ENERGY SOLUTIONS INC | Energy | $1.76B | 0.06% |
135BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.06% |
136FTRE | FORTREA HOLDINGS INC | Healthcare | $1.68B | 0.06% |
137EYE | NATIONAL VISION HOLDINGS INC | Consumer Cyclical | $1.66B | 0.06% |
138VIR | VIR BIOTECHNOLOGY INC | Healthcare | $1.59B | 0.06% |
139NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.59B | 0.06% |
140ENOV | ENOVIS CORP | Industrials | $1.56B | 0.06% |
141IART | INTEGRA LIFESCIENCES HOLDINGS CORP | Healthcare | $1.50B | 0.05% |
142CNXC | CONCENTRIX CORP | Technology | $1.49B | 0.05% |
143PRGO | PERRIGO CO PLC | Healthcare | $1.48B | 0.05% |
144INSP | INSPIRE MEDICAL SYSTEMS INC | Healthcare | $1.46B | 0.05% |
145MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.05% |
146YELP | YELP INC | Communication Services | $1.44B | 0.05% |
147KMTS | KESTRA MEDICAL TECHNOLOGIES LTD | Healthcare | $1.43B | 0.05% |
148BLFS | BIOLIFE SOLUTIONS INC | Healthcare | $1.42B | 0.05% |
149BRBR | BELLRING BRANDS INC | Consumer Defensive | $1.41B | 0.05% |
150FMC | FMC CORP | Basic Materials | $1.40B | 0.05% |
151AI | C3AI INC | Technology | $1.37B | 0.05% |
152CXM | SPRINKLR INC | Technology | $1.37B | 0.05% |
153STAA | STAAR SURGICAL CO | Healthcare | $1.32B | 0.05% |
154ATEC | ALPHATEC HOLDINGS INC | Healthcare | $1.31B | 0.05% |
155HLIT | HARMONIC INC | Technology | $1.31B | 0.05% |
156CNMD | CONMED CORP | Healthcare | $1.30B | 0.05% |
157XNCR | XENCOR INC | Healthcare | $1.30B | 0.05% |
158INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.05% |
159AMPL | AMPLITUDE INC | Technology | $1.27B | 0.04% |
160CDRE | CADRE HOLDINGS INC | Industrials | $1.24B | 0.04% |
161IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.04% |
162CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $1.24B | 0.04% |
163AORT | ARTIVION INC | Healthcare | $1.22B | 0.04% |
164DRTS | ALPHA TAU MEDICAL LTD | Healthcare | $1.19B | 0.04% |
165QDEL | QUIDELORTHO CORP | Healthcare | $1.19B | 0.04% |
166TNDM | TANDEM DIABETES CARE INC | Healthcare | $1.17B | 0.04% |
167AVNS | AVANOS MEDICAL INC | Healthcare | $1.17B | 0.04% |
168MYE | MYERS INDUSTRIES INC | Consumer Cyclical | $1.17B | 0.04% |
169MGTX | MEIRAGTX HOLDINGS PLC | Healthcare | $1.15B | 0.04% |
170EYPT | EYEPOINT INC | Healthcare | $1.12B | 0.04% |
171SECZ | SECURITIZE CORP | Technology | $1.11B | 0.04% |
172PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.04% |
173PCT | PURECYCLE TECHNOLOGIES INC | Industrials | $1.09B | 0.04% |
174CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $1.09B | 0.04% |
175NMAX | NEWSMAX INC | Communication Services | $1.08B | 0.04% |
176GRPN | GROUPON INC | Communication Services | $1.06B | 0.04% |
177AEVA | AEVA TECHNOLOGIES INC | Consumer Cyclical | $1.05B | 0.04% |
178AVTX | AVALO THERAPEUTICS INC | Healthcare | $1.02B | 0.04% |
179PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.01B | 0.04% |
180BVS | BIOVENTUS INC | Healthcare | $1.01B | 0.04% |
181VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.03% |
182MUX | MCEWEN INC | Basic Materials | $978M | 0.03% |
183KURA | KURA ONCOLOGY INC | Healthcare | $964M | 0.03% |
184ANNX | ANNEXON INC | Healthcare | $950M | 0.03% |
185AOSL | ALPHA & OMEGA SEMICONDUCTOR LTD | Technology | $936M | 0.03% |
186REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.03% |
187NX | QUANEX BUILDING PRODUCTS CORP | Basic Materials | $835M | 0.03% |
188FOXF | FOX FACTORY HOLDING CORP | Consumer Cyclical | $798M | 0.03% |
189CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $777M | 0.03% |
190SIBN | SI-BONE INC | Healthcare | $771M | 0.03% |
191BBNX | BETA BIONICS INC | Healthcare | $771M | 0.03% |
192KRT | KARAT PACKAGING INC | Consumer Cyclical | $760M | 0.03% |
193WEST | WESTROCK COFFEE CO | Consumer Defensive | $749M | 0.03% |
194IBTA | IBOTTA INC | Technology | $734M | 0.03% |
195CLYM | CLIMB BIO INC | Healthcare | $727M | 0.03% |
196AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.03% |
197CBLL | CERIBELL INC | Healthcare | $710M | 0.03% |
198SPRY | ARS PHARMACEUTICALS INC | Healthcare | $695M | 0.02% |
199SWBI | SMITH & WESSON BRANDS INC | Industrials | $665M | 0.02% |
200CNNE | CANNAE HOLDINGS INC | Consumer Cyclical | $657M | 0.02% |
201HELE | HELEN OF TROY LTD | Consumer Defensive | $655M | 0.02% |
202EVH | EVOLENT HEALTH INC | Healthcare | $654M | 0.02% |
203TCMD | TACTILE SYSTEMS TECHNOLOGY INC | Healthcare | $648M | 0.02% |
204KLC | KINDERCARE LEARNING COMPANIES INC | Consumer Defensive | $618M | 0.02% |
205TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.02% |
206FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.02% |
207RGR | STURM RUGER & CO INC | Industrials | $604M | 0.02% |
208NTGR | NETGEAR INC | Technology | $602M | 0.02% |
209NGNE | NEUROGENE INC | Healthcare | $590M | 0.02% |
210ALIT | ALIGHT INC | Technology | $584M | 0.02% |
211MYGN | MYRIAD GENETICS INC | Healthcare | $584M | 0.02% |
212ANGO | ANGIODYNAMICS INC | Healthcare | $558M | 0.02% |
213RYAM | RAYONIER ADVANCED MATERIALS INC | Basic Materials | $555M | 0.02% |
214EGY | VAALCO ENERGY INC | Energy | $553M | 0.02% |
215NPCE | NEUROPACE INC | Healthcare | $548M | 0.02% |
216YEXT | YEXT INC | Technology | $535M | 0.02% |
217TOI | ONCOLOGY INSTITUTE INC | Healthcare | $535M | 0.02% |
218TASK | TASKUS INC | Technology | $534M | 0.02% |
219ARVN | ARVINAS INC | Healthcare | $517M | 0.02% |
220DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $517M | 0.02% |
221RGNX | REGENXBIO INC | Healthcare | $511M | 0.02% |
222NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.02% |
223KIDS | ORTHOPEDIATRICS CORP | Healthcare | $494M | 0.02% |
224SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.02% |
225OFIX | ORTHOFIX MEDICAL INC | Healthcare | $468M | 0.02% |
226IPI | INTREPID POTASH INC | Basic Materials | $459M | 0.02% |
227CLPT | CLEARPOINT NEURO INC | Healthcare | $454M | 0.02% |
228PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.02% |
229KYTX | KYVERNA THERAPEUTICS INC | Healthcare | $453M | 0.02% |
230VREX | VAREX IMAGING CORP | Healthcare | $444M | 0.02% |
231CCRN | CROSS COUNTRY HEALTHCARE INC | Healthcare | $428M | 0.02% |
232ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.02% |
233NVEC | NVE CORP | Technology | $418M | 0.01% |
234CLFD | CLEARFIELD INC | Technology | $416M | 0.01% |
235STRO | SUTRO BIOPHARMA INC | Healthcare | $391M | 0.01% |
236MGPI | MGP INGREDIENTS INC | Consumer Defensive | $382M | 0.01% |
237UPB | UPSTREAM BIO INC | Healthcare | $382M | 0.01% |
238EOLS | EVOLUS INC | Healthcare | $377M | 0.01% |
239CEPT | CANTOR EQUITY PARTNERS II INC | Industrials | $376M | 0.01% |
240ZNTL | ZENTALIS PHARMACEUTICALS INC | Healthcare | $364M | 0.01% |
241ELMD | ELECTROMED INC | Healthcare | $349M | 0.01% |
242SEG | SEAPORT ENTERTAINMENT GROUP INC | Real Estate | $332M | 0.01% |
243XPOF | XPONENTIAL FITNESS INC | Consumer Cyclical | $328M | 0.01% |
244VNDA | VANDA PHARMACEUTICALS INC | Healthcare | $327M | 0.01% |
245LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $311M | 0.01% |
246TKNO | ALPHA TEKNOVA INC | Healthcare | $291M | 0.01% |
247SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.01% |
248TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $268M | 0.01% |
249HCKT | HACKETT GROUP INC | Technology | $261M | 0.01% |
250SRZN | SURROZEN INC | Healthcare | $255M | 0.01% |
251RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.01% |
252ARTV | ARTIVA BIOTHERAPEUTICS INC | Healthcare | $241M | 0.01% |
253QUIK | QUICKLOGIC CORP | Technology | $237M | 0.01% |
254GTE | GRAN TIERRA ENERGY INC | Energy | $233M | 0.01% |
255RXST | RXSIGHT INC | Healthcare | $230M | 0.01% |
256SMTI | SANARA MEDTECH INC | Healthcare | $229M | 0.01% |
257UP | WHEELS UP EXPERIENCE INC | Industrials | $229M | 0.01% |
258UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.01% |
259KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
260KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
261FOCL | FOCAL INC | Healthcare | $204M | 0.01% |
262ANIK | ANIKA THERAPEUTICS INC | Healthcare | $203M | 0.01% |
263AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.01% |
264PDEX | PRO DEX INC | Healthcare | $183M | 0.01% |
265EAF | GRAFTECH INTERNATIONAL LTD | Industrials | $181M | 0.01% |
266INFU | INFUSYSTEM HOLDINGS INC | Healthcare | $180M | 0.01% |
267INGN | INOGEN INC | Healthcare | $178M | 0.01% |
268KRRO | KORRO BIO INC | Healthcare | $177M | 0.01% |
269AOUT | AMERICAN OUTDOOR BRANDS INC | Industrials | $174M | 0.01% |
270ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
271NLOP | NET LEASE OFFICE PROPERTIES | Real Estate | $172M | 0.01% |
272MRDN | MERIDIAN HOLDINGS INC | Communication Services | $171M | 0.01% |
273RCEL | AVITA MEDICAL INC | Healthcare | $157M | 0.01% |
274DMRC | DIGIMARC CORP | Technology | $133M | 0.00% |
275FIRY | FIRY INC | Technology | $130M | 0.00% |
276AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.00% |
277INSG | INSEEGO CORP | Technology | $122M | 0.00% |
278STHO | STAR HOLDINGS | Real Estate | $114M | 0.00% |
279LAKE | LAKELAND INDUSTRIES INC | Consumer Cyclical | $113M | 0.00% |
280CPIX | CUMBERLAND PHARMACEUTICALS INC | Healthcare | $103M | 0.00% |
281CHRN | CHRONOSCALE CORP | Industrials | $94M | 0.00% |
282GEOS | GEOSPACE TECHNOLOGIES CORP | Energy | $88M | 0.00% |
283AEYE | AUDIOEYE INC | Technology | $82M | 0.00% |
284PIII | P3 HEALTH PARTNERS INC | Healthcare | $78M | 0.00% |
285SEAT | VIVID SEATS INC | Communication Services | $78M | 0.00% |
286ACET | ADICET BIO INC | Healthcare | $76M | 0.00% |
287AIRG | AIRGAIN INC | Technology | $76M | 0.00% |
288CLNN | CLENE INC | Healthcare | $76M | 0.00% |
289SCLX | SCILEX HOLDING CO | Healthcare | $72M | 0.00% |
290BGSF | BGSF INC | Industrials | $65M | 0.00% |
291EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
292SKIL | SKILLSOFT CORP | Consumer Defensive | $58M | 0.00% |
293APT | ALPHA PRO TECH LTD | Basic Materials | $53M | 0.00% |
294MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.00% |
295EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
296TIL | INSTIL BIO INC | Healthcare | $50M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $2.83T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 95% toward Large, 70% toward Growth. +6% unclassified (63 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual32.4%Margin-7.4%
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators agree, which is mild evidence the number isn’t an artefact of one method.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 30.7% | 13.4% |
| 3 yearsp.a. | 14.4% | -16.5% |
| 5 yearsp.a. | 9.4% | -2.5% |
| 10 yearsp.a. | 10.3% | -3.5% |
| Since inceptionp.a. | 7.2% | -2.2% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 16.1% | 5.9% |
| 2025 | 12.8% | -16.8% |
| 2024 | 14.1% | -32.3% |
| 2023 | 42.7% | 12.5% |
| 2022 | -26.3% | 17.9% |
| 2021 | 17.9% | 16.7% |
| 2020 | 4.5% | -31.1% |
| 2019 | 26.8% | 9.5% |
| 2018 | -10.4% | 5.2% |
| 2017 | 17.8% | -7.1% |
| 2016 | 10.8% | 3.7% |
| 2015 | 6.2% | 1.9% |
| 2014 | 20.6% | 8.2% |
| 2013 | 30.2% | -5.7% |
| 2012 | 15.4% | -11.5% |
| 2011 | -1.7% | -6.7% |
| 2010 | 15.4% | -6.9% |
| 2009 | 26.4% | -7.4% |
| 2008 | -38.8% | -6.4% |
| 2007 | 10.7% | -8.9% |
| 2006 | 22.7% | 13.3% |
| 2005 | -1.1% | -10.0% |
| 2004 | 4.2% | -16.4% |
| 2003 | 35.9% | -7.5% |
| 2002 | -27.7% | 6.2% |
| 2001 | -7.2% | 45.2% |
| 2000 | -14.1% | 32.2% |
| 1999 | 29.5% | -23.6% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry DelEqu Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelEqu signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.